Clinical trial
A Retrospective and Prospective Non-interventional Open Label Study to Assess the Real Life of Treatment-naive Patients With Wet Age-related Macular Degeneration in Routine Clinical Practice in France and Starting an Anti VEGF Therapy With Aflibercept
NCT02279537 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective and Prospective Non-interventional Open Label Study to Assess the Real Life of Treatment-naive Patients With Wet Age-related Macular Degeneration in Routine Clinical Practice in France and Starting an Anti VEGF Therapy With Aflibercept
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 2, 2014
- Completion date
- April 17, 2019
- Enrollment
- 593 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.